Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Decrease in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a significant decrease in short interest in May. As of May 29th, there was short interest totaling 69 shares, a decrease of 90.6% from the May 14th total of 734 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily volume of 2,285 shares, the short-interest ratio is currently 0.0 days.

Innovator IBD Breakout Opportunities ETF Trading Down 0.5%

Shares of BOUT stock traded down $0.21 during trading hours on Tuesday, reaching $45.75. 1,060 shares of the company’s stock were exchanged, compared to its average volume of 4,551. The stock’s 50 day moving average is $44.42 and its 200-day moving average is $40.56. The company has a market cap of $16.01 million, a price-to-earnings ratio of 28.69 and a beta of 1.04. Innovator IBD Breakout Opportunities ETF has a fifty-two week low of $35.05 and a fifty-two week high of $48.05.

Hedge Funds Weigh In On Innovator IBD Breakout Opportunities ETF

Large investors have recently made changes to their positions in the business. Osaic Holdings Inc. increased its position in shares of Innovator IBD Breakout Opportunities ETF by 39.7% in the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after acquiring an additional 597 shares during the period. Susquehanna International Group LLP increased its position in shares of Innovator IBD Breakout Opportunities ETF by 42.6% in the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after acquiring an additional 7,817 shares during the period. Finally, Comprehensive Wealth Management LLC increased its position in shares of Innovator IBD Breakout Opportunities ETF by 122.0% in the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after acquiring an additional 12,859 shares during the period.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.